Metabolism, Excretion
Understanding the processes of metabolism and excretion is crucial in toxicology
Drug Metabolism
- Definition: The process by which the body chemically alters a toxic substance, often to facilitate its elimination
- Primary Site of Metabolism: Liver
- Other Sites: Kidneys, intestines, lungs, and plasma
-
Purpose of Metabolism
- Convert lipid-soluble toxic substances into more water-soluble metabolites, facilitating their excretion in the urine
- Detoxify by converting toxic substances into less harmful metabolites
- Bioactivation: Convert relatively harmless substances into more toxic metabolites
-
Phases of Metabolism
- Phase I Reactions: Introduce or expose a functional group on the toxic substance molecule through oxidation, reduction, or hydrolysis
- Phase II Reactions: Conjugate a polar molecule to the toxic substance molecule, such as glucuronic acid, sulfate, or glutathione
Phase I Metabolism
-
Oxidation
- Addition of oxygen or removal of hydrogen atoms from the toxic substance molecule
- Enzymes involved: Cytochrome P450 (CYP) enzymes
- Examples of reactions: Hydroxylation, epoxidation, N-oxidation, S-oxidation
-
Reduction
- Addition of hydrogen atoms or electrons to the toxic substance molecule
- Enzymes involved: Reductases
- Examples of reactions: Reduction of nitro groups, azo groups, and carbonyl groups
-
Hydrolysis
- Addition of water to break a chemical bond
- Enzymes involved: Esterases, amidases, peptidases
- Examples of reactions: Hydrolysis of esters, amides, and peptides
Phase II Metabolism
-
Glucuronidation
- Addition of glucuronic acid to the toxic substance molecule
- Enzymes involved: UDP-glucuronosyltransferases (UGTs)
- Results in highly water-soluble metabolites that are easily excreted in the urine
-
Sulfation
- Addition of a sulfate group to the toxic substance molecule
- Enzymes involved: Sulfotransferases (SULTs)
- Results in water-soluble metabolites that are easily excreted in the urine
-
Acetylation
- Addition of an acetyl group to the toxic substance molecule
- Enzymes involved: N-acetyltransferases (NATs)
- Genetic polymorphisms in NAT enzymes can affect the metabolism of some toxic substances
-
Glutathione Conjugation
- Addition of glutathione to the toxic substance molecule
- Enzymes involved: Glutathione S-transferases (GSTs)
- Important for detoxifying reactive metabolites, such as those formed during acetaminophen metabolism
-
Methylation
- Addition of a methyl group to the toxic substance molecule
- Enzymes involved: Methyltransferases
- Can either activate or inactivate drugs
Cytochrome P450 (CYP) Enzymes
- Definition: A superfamily of heme-containing monooxygenases that catalyze the oxidation of many drugs, toxins, and endogenous compounds
- Location: Primarily in the liver, but also present in other tissues
- Importance in Toxicology: Responsible for the metabolism of many toxic substances
-
Key CYP Enzymes
- CYP3A4: Metabolizes the largest number of drugs and toxins
- CYP2D6: Metabolizes many psychiatric and cardiovascular drugs
- CYP2C9: Metabolizes nonsteroidal anti-inflammatory drugs (NSAIDs) and warfarin
- CYP2E1: Metabolizes ethanol, acetaminophen, and some volatile organic compounds
Factors Affecting Drug Metabolism
-
Genetic Factors
- Genetic polymorphisms in drug-metabolizing enzymes can affect the rate of metabolism
- Individuals can be classified as poor metabolizers, intermediate metabolizers, extensive metabolizers, or ultra-rapid metabolizers
-
Age
- Infants have immature metabolic enzyme systems
- Elderly individuals may have decreased liver function and reduced enzyme activity
-
Disease States
- Liver disease: Reduces metabolic enzyme activity
- Kidney disease: Affects drug clearance and can lead to drug accumulation
-
Drug Interactions
- Enzyme Inducers: Increase the activity of metabolizing enzymes, leading to decreased levels of toxicant
- Enzyme Inhibitors: Decrease the activity of metabolizing enzymes, leading to increased levels of toxicant
-
Diet and Environmental Factors
- Grapefruit juice: Inhibits CYP3A4
- Smoking: Induces CYP1A2
-
Gender
- Differences in hormone levels and body composition can affect drug metabolism
Excretion
- Definition: The process by which the body eliminates a toxic substance or its metabolites
-
Primary Routes of Excretion
- Kidneys: Most toxic substances are excreted in the urine
- Liver: Some toxic substances are excreted in the bile and eliminated in the feces
- Other Routes: Lungs, sweat, saliva, breast milk
-
Renal Excretion
- Glomerular Filtration: Toxic substances and small molecules are filtered from the blood into the renal tubules
- Only unbound (free) substance can be filtered
- Tubular Secretion: Active transport of toxic substances from the blood into the renal tubules
- Can be affected by drug interactions
- Tubular Reabsorption: Passive or active transport of toxic substances from the renal tubules back into the blood
- Lipid-soluble toxic substances are more readily reabsorbed
- Urine pH can affect the reabsorption of weak acids and bases
- Glomerular Filtration: Toxic substances and small molecules are filtered from the blood into the renal tubules
-
Biliary Excretion
- Toxic substances and metabolites are transported from the liver into the bile
- Bile is secreted into the small intestine and eliminated in the feces
- Some toxic substances undergo enterohepatic circulation, where they are reabsorbed from the intestine back into the blood
-
Clearance (CL)
- A measure of the body’s efficiency in eliminating a toxic substance from the body
- Total Clearance: Sum of all clearance pathways (renal, hepatic, and other)
- Renal Clearance: The volume of plasma from which a toxic substance is completely removed by the kidneys per unit of time
- Hepatic Clearance: The volume of plasma from which a toxic substance is completely removed by the liver per unit of time
-
Factors Affecting Excretion
- Renal Function: Glomerular filtration rate (GFR), tubular secretion, and tubular reabsorption affect renal excretion
- Liver Function: Bile flow and hepatic metabolism affect biliary excretion
- Substance Properties: Molecular size, ionization, and protein binding affect excretion
- Drug Interactions: Some drugs can affect the excretion of other substances
- Urine pH: Can influence the excretion of weak acids and bases
Clinical Significance
-
Understanding of Metabolism and Excretion Is Crucial for
- Predicting the toxicity of substances
- Assessing individual susceptibility to toxic effects
- Developing effective treatments for poisoning
- Designing strategies for preventing exposure to toxic substances
- Altered Drug Metabolism Can Affect Toxicity * Enzyme inducers can decrease toxicant concentrations * Enzyme inhibitors can increase toxicant concentrations
-
Pharmacogenomics
- Genetic testing can determine specific treatment to detox or remove the substance from the system
- Dosage Adjustments in Patients with Renal or Hepatic Impairment * Knowing kidney or liver capabilities will allow for proper dosage adjustments
- Therapeutic Drug Monitoring (TDM) * Some drugs may be used as treatments
Key Terms
- Drug Metabolism: The process by which the body chemically alters a drug
- Enzyme Induction: Increased activity of drug-metabolizing enzymes
- Enzyme Inhibition: Decreased activity of drug-metabolizing enzymes
- Cytochrome P450 (CYP) Enzymes: A superfamily of heme-containing monooxygenases
- Prodrug: An inactive drug that is metabolized to an active metabolite
- Drug Excretion: The process by which the body eliminates a drug or its metabolites
- Glomerular Filtration: The process by which drugs and small molecules are filtered from the blood into the renal tubules
- Tubular Secretion: The active transport of drugs from the blood into the renal tubules
- Tubular Reabsorption: The transport of drugs from the renal tubules back into the blood
- Biliary Excretion: The excretion of drugs and metabolites from the liver into the bile
- Enterohepatic Circulation: The reabsorption of drugs from the intestine back into the blood
- Clearance (CL): A measure of the body’s efficiency in eliminating a drug from the body
- Drug-Drug Interactions (DDIs): The interactions between two or more drugs that can affect their absorption, distribution, metabolism, or excretion
- Pharmacogenomics: The study of how genes affect a person’s response to drugs
- Genetic Polymorphism: Variation in the DNA sequence among individuals
- Bioactivation: Metabolic activation of a substance to become toxic